Dr. Katharine Offer
Claim this profileHackensack University Medical Center
Expert in Tumors
Expert in Neuroblastoma
35 reported clinical trials
67 drugs studied
Area of expertise
1Tumors
Global LeaderStage I
Stage IV
Stage II
2Neuroblastoma
Global LeaderMYC positive
Stage IV
MYC negative
Affiliated Hospitals
Clinical Trials Katharine Offer is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Chemotherapy
for Cancer
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Drugs used in chemotherapy, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.
Recruiting2 awards Phase 326 criteria
More about Katharine Offer
Clinical Trial Related7 years of experience running clinical trials · Led 35 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Katharine Offer has experience with
- Cyclophosphamide
- Cisplatin
- Carboplatin
- Etoposide
- Larotrectinib
- Dinutuximab
Breakdown of trials Katharine Offer has run
Tumors
Neuroblastoma
Osteosarcoma
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Katharine Offer specialize in?
Katharine Offer focuses on Tumors and Neuroblastoma. In particular, much of their work with Tumors has involved Stage I patients, or patients who are Stage IV.
Is Katharine Offer currently recruiting for clinical trials?
Yes, Katharine Offer is currently recruiting for 10 clinical trials in Hackensack New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Katharine Offer has studied deeply?
Yes, Katharine Offer has studied treatments such as Cyclophosphamide, Cisplatin, Carboplatin.
What is the best way to schedule an appointment with Katharine Offer?
Apply for one of the trials that Katharine Offer is conducting.
What is the office address of Katharine Offer?
The office of Katharine Offer is located at: Hackensack University Medical Center, Hackensack, New Jersey 07601 United States. This is the address for their practice at the Hackensack University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.